Gori, Alessia
 Distribuzione geografica
Continente #
AS - Asia 143
NA - Nord America 95
EU - Europa 76
SA - Sud America 24
AF - Africa 1
Totale 339
Nazione #
SG - Singapore 98
US - Stati Uniti d'America 92
HK - Hong Kong 34
IT - Italia 30
BR - Brasile 23
DE - Germania 14
RU - Federazione Russa 14
NL - Olanda 6
FI - Finlandia 4
AT - Austria 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
JO - Giordania 2
MX - Messico 2
VN - Vietnam 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CN - Cina 1
CR - Costa Rica 1
IN - India 1
IQ - Iraq 1
NP - Nepal 1
RO - Romania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 339
Città #
Singapore 80
Hong Kong 34
Santa Clara 17
Rome 12
Milan 11
Nuremberg 8
Munich 4
Amsterdam 3
Helsinki 3
Amman 2
Brno 2
Council Bluffs 2
Ho Chi Minh City 2
London 2
Messina 2
The Dalles 2
Anápolis 1
Aparecida de Goiânia 1
Arcoverde 1
Ashburn 1
Baghdad 1
Baianópolis 1
Belo Horizonte 1
Brumadinho 1
Bucharest 1
Faridabad 1
Franca 1
Inhumas 1
Jequié 1
Johannesburg 1
La Francia 1
Los Angeles 1
Manhuaçu 1
Moscow 1
Ourilândia do Norte Municipality 1
Parobé 1
Passo Fundo 1
Passo de Torres 1
Pelotas 1
Poço Redondo 1
Puebla City 1
Reno 1
Rio Grande 1
Samara 1
San José 1
Serra 1
Sorocaba 1
São Gotardo 1
São Luiz Gonzaga 1
São Paulo 1
Tashkent 1
Tirana 1
Três Rios 1
Vienna 1
Yerevan 1
Zamora 1
Totale 226
Nome #
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 40
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 36
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 33
Amino acid variability of small molecule inhibitors and mAbs target sites in globally circulating RSV strains 33
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 30
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 29
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 28
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 28
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 25
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 24
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 20
null 20
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 16
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 12
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 10
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 4
Totale 388
Categoria #
all - tutte 2.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202449 0 0 0 0 0 0 0 0 4 42 0 3
2024/2025339 11 85 39 31 10 44 47 14 53 5 0 0
Totale 388